ENvue Medical (FEED) EBITDA Margin Growth (3y) (2017 - 2026)
ENvue Medical (FEED) EBITDA Margin Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -184.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -763.00 |
| 10 | ENvue Medical | 1.18 Mn | -1.09 Mn | -55,000.00 | -27,028.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27,028.00 |
| Dec 31, 2025 | -642,259.00 |
| Sep 30, 2025 | 64,136.00 |
| Jun 30, 2025 | -54,342.00 |
| Mar 31, 2025 | 22,814.00 |
| Dec 31, 2024 | 1,531.00 |
| Sep 30, 2024 | -8,403.00 |
| Jun 30, 2024 | 22,914.00 |
| Mar 31, 2024 | 121,406.00 |
| Dec 31, 2023 | 165,147.00 |
| Sep 30, 2023 | 38,971.00 |
| Jun 30, 2023 | 20,253.00 |
| Mar 31, 2023 | 49,759.00 |
| Dec 31, 2022 | 309,865.00 |
| Sep 30, 2022 | -16,743.00 |
| Jun 30, 2022 | 7,924.00 |
| Mar 31, 2022 | 240,510.00 |
| Dec 31, 2021 | 220,020.00 |
| Sep 30, 2021 | 228,161.00 |
| Jun 30, 2021 | 31,336.00 |